Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2D6, CYP2C19, CYP2B6, SLC6A4, and HTR2A Genotypes and Serotonin …
CA Bousman, JM Stevenson… - Clinical …, 2023 - Wiley Online Library
Serotonin reuptake inhibitor antidepressants, including selective serotonin reuptake
inhibitors (SSRIs; ie, citalopram, escitalopram, fluoxetine, fluvoxamine, paroxetine, and …
inhibitors (SSRIs; ie, citalopram, escitalopram, fluoxetine, fluvoxamine, paroxetine, and …
Cytochrome P450 enzymes and drug metabolism in humans
M Zhao, J Ma, M Li, Y Zhang, B Jiang, X Zhao… - International journal of …, 2021 - mdpi.com
Human cytochrome P450 (CYP) enzymes, as membrane-bound hemoproteins, play
important roles in the detoxification of drugs, cellular metabolism, and homeostasis. In …
important roles in the detoxification of drugs, cellular metabolism, and homeostasis. In …
Clinical Pharmacogenetics Implementation Consortium Guideline for CYP2D6, OPRM1, and COMT Genotypes and Select Opioid Therapy
Opioids are mainly used to treat both acute and chronic pain. Several opioids are
metabolized to some extent by CYP2D6 (codeine, tramadol, hydrocodone, oxycodone, and …
metabolized to some extent by CYP2D6 (codeine, tramadol, hydrocodone, oxycodone, and …
A Review of the Important Role of CYP2D6 in Pharmacogenomics
C Taylor, I Crosby, V Yip, P Maguire, M Pirmohamed… - Genes, 2020 - mdpi.com
Cytochrome P450 2D6 (CYP2D6) is a critical pharmacogene involved in the metabolism of~
20% of commonly used drugs across a broad spectrum of medical disciplines including …
20% of commonly used drugs across a broad spectrum of medical disciplines including …
Pharmacogenetics guidelines: overview and comparison of the DPWG, CPIC, CPNDS, and RNPGx guidelines
H Abdullah-Koolmees, AM Van Keulen… - Frontiers in …, 2021 - frontiersin.org
Many studies have shown that the efficacy and risk of side effects of drug treatment is
influenced by genetic variants. Evidence based guidelines are essential for implementing …
influenced by genetic variants. Evidence based guidelines are essential for implementing …
Association of CYP2C19 and CYP2D6 poor and intermediate metabolizer status with antidepressant and antipsychotic exposure: a systematic review and meta …
F Milosavljević, N Bukvić, Z Pavlović, Č Miljević… - JAMA …, 2021 - jamanetwork.com
Importance Precise estimation of the drug metabolism capacity for individual patients is
crucial for adequate dose personalization. Objective To quantify the difference in the …
crucial for adequate dose personalization. Objective To quantify the difference in the …
Review and consensus on pharmacogenomic testing in psychiatry
The implementation of pharmacogenomic (PGx) testing in psychiatry remains modest, in part
due to divergent perceptions of the quality and completeness of the evidence base and …
due to divergent perceptions of the quality and completeness of the evidence base and …
Dutch Pharmacogenetics Working Group (DPWG) guideline for the gene-drug interaction between CYP2D6, CYP3A4 and CYP1A2 and antipsychotics
L Beunk, M Nijenhuis, B Soree… - European Journal of …, 2024 - nature.com
Abstract The Dutch Pharmacogenetics Working Group (DPWG) aims to facilitate
pharmacogenetics implementation in clinical practice by developing evidence-based …
pharmacogenetics implementation in clinical practice by developing evidence-based …
Phenoconversion of cytochrome P450 metabolism: a systematic review
Phenoconversion is the mismatch between the individual's genotype-based prediction of
drug metabolism and the true capacity to metabolize drugs due to nongenetic factors. While …
drug metabolism and the true capacity to metabolize drugs due to nongenetic factors. While …
PharmVar GeneFocus: CYP2C19
MR Botton, M Whirl‐Carrillo… - Clinical …, 2021 - Wiley Online Library
The Pharmacogene Variation Consortium (PharmVar) catalogues star (*) allele
nomenclature for the polymorphic human CYP2C19 gene. CYP2C19 genetic variation …
nomenclature for the polymorphic human CYP2C19 gene. CYP2C19 genetic variation …